IFN‐γ released by tumor‐specific T cells can identify tumor cells and their associated antigens, triggering the upregulation of proteins such as effector molecules and major histocompatibility complex (MHC) proteins that inhibit tumor growth or promote apoptosis. This evidence concerns the gene IFNG and neoplasm.